Pharmacogenomics (PGx) Community

Description & Goals

The Pharmacogenomics Community combines the disciplines of biochemistry, biophysics, genetics, molecular biology, bioinformatics, and pharmacology to elucidate the mechanisms of drug action, toxicity, metabolism and transport and to identify genetic determinants of variability in drug exposure, response and toxicity.

Community Goals

Facilitate interaction and collaboration between members of the Pharmacogenomics Community via social media and networking opportunities
Spur interest and growth in the area of pharmacogenomics
Act as the primary home for researchers in the area of pharmacogenomics
Support member engagement in the Precision Medicine Initiative

Community Connection

Join the LinkedIn Group.

Programs of Interest

University of Florida Training Program
The University of Florida announces a new training program funded by the National Institutes of Health’s National Human Genomic Research Institute. The Program for Applied Research and Development in Genomic Medicine, or PARADIGM, offers trainees mentoring from world-renowned scientists, clinical exposure in multiple areas of genomic medicine and stimulating career development opportunities within the robust, interdisciplinary research environment at UF. Learn more here.

Are you interested in volunteering within the PMG Community? Email your interest to Jason Karnes, PharmD, PhD, or update your involvement interests online.

Past Webinars

The webinars below can be accessed in the Members Only Webinar Library: Access Library

Cost Effectiveness for Pharmacogenetic Testing: The U-PGx Project Experience
Pre-Emptive Pharmacogenomic Testing Reduces the Risk of Adverse Drug Reactions by 30%: The Time for Implementation is Now
Interrogating Germline Genetic Variation for Pharmacogenomic Discovery, Validation, and Clinical Implementation
Clinical Implementation of Pharmacogenomic (PGx) Profile Service at Mayo Clinic
Building Bridges Between Industry, Academia, Health Care Systems and Communities to Advance Pharmacogenomics and Precision Medicine
Taking A Second Look: A Type 2 Diabetes Subtype Responsive to Intensive Glycemia Treatment in the ACCORD Trial
Pharmacogenomics Studies in Caribbean Hispanics Bridging the Gap to Reduce Healthcare Disparities
2020 ASCPT-FDA William B Abrams Award Lecture: Clinical Implementation of Pharmacogenetics
Standardizing CYP2D6 Genotype to Phenotype Translation and Its Impact on Clinical Implementation
Drug Re-purposing Opportunities Using Shared Gene Expression Molecular Signatures - Case Studies in Neurodegenerative Diseases and Infections
Implementation of a Clinical Pharmacogenomics Service in a Pediatric Health System
From a Genotype to Multiple Phenotypes: Drug-Induced and Disease-Induced Phenoconversion
Functional Annotation of Variants of Uncertain Significance
The Dutch Pharmacogenetics Working Group Guidelines: Putting Pharmacogenetics into Practice
Drug-Drug Interactions of Gene-Drug Interactions
Standardizing Terms for Clinical Pharmacogenetic Test Results
Journal Club "Comparison of Genome Sequencing and Clinical Genotyping for Pharmacogenes"
Incorporating Pharmacogenetic Testing into Graduate Pharmacy Curriculum Significantly Enhances Students Knowledge and Attitude towards Personalized and Precision Medicine
Integration of Precision Medicine Initiative into Clinical Practice